Key statistics
As of last trade, Evotec SE (EVTX:GER) traded at 9.73, 92.29% above the 52 week low of 5.06 set on Aug 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.00 |
---|---|
High | 10.00 |
Low | 9.72 |
Bid | 9.72 |
Offer | 9.73 |
Previous close | 10.07 |
Average volume | 2.89m |
---|---|
Shares outstanding | 177.55m |
Free float | 158.04m |
P/E (TTM) | -- |
Market cap | 1.79bn EUR |
EPS (TTM) | -0.9668 EUR |
Data delayed at least 15 minutes, as of Nov 22 2024 12:43 GMT.
More ▼
- EQS-Adhoc: Comment on media report
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
- EQS-News: Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
- EQS-News: Evotec SE to announce results for the first nine months 2024 on 06 November 2024
- EQS-News: Evotec and Bristol Myers Squibb expand proteomics partnership
- EQS-DD: Evotec SE: Laetitia Rouxel, Restricted shares granted as Short-Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system
- EQS-News: Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
- EQS-News: Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU)
- EQS-DD: Evotec SE: Dr. Christian Wojczewski, buy
More ▼